Skip to main content
Erschienen in: International Urology and Nephrology 6/2017

16.03.2017 | Urology - Original Paper

Neutrophil to Lymphocyte Ratio as a predictor of early penile prosthesis implant infection

verfasst von: Deniz Bolat, Yusuf Kadir Topcu, Ozgu Aydogdu, Suleyman Minareci, Cetin Dincel

Erschienen in: International Urology and Nephrology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the predictive value of preoperative serum neutrophil-to-lymphocyte ratio (NLR) on the development of postoperative infections in patients undergoing penile prosthesis implantation (PPI).

Methods

We retrospectively analyzed the data of 361 patients who underwent PPI over a 4-year period with at least 1-year follow-up. Demographics, blood results, and postoperative 1-year complications were recorded. Recommended cutoff values of NLR for early postoperative infectious complications were determined using receiver operating characteristic analysis.

Results

A total of 153 patients with the mean age of 56.4 ± 8 years were included in the study. Mean follow-up time was 56.7 ± 30.4 months (12–108 months). Early postoperative infectious complications were occured in 18 patients (11.8%). These infections were prosthesis infection in 8 patients (5.2%), wound infection in 6 patients (3.9%), and urinary tract infection in 4 patients (2.6%). All these complications were occured within the first year of the surgery. Mean NLR was statistically higher in patients with postoperative complications when compared with uncomplicated cases (7.2 ± 3.9 vs. 2.2 ± 1.4, p < 0.001, respectively) Using a cut point of 6.2, preoperative NLR predicted postoperative complications with a sensitivity of 67% and specificity of 99%.

Conclusions

This study is the first to investigate the relationship between NLR and early postoperative infection as a complication of PPI. The results demonstrated that the NLR value could be a potential laboratory parameter for predicting early postoperative infectious complications in patients undergoing PPI.
Literatur
1.
Zurück zum Zitat Antonini G, Busetto GM, De Berardinis E, Giovannone R, Vicini P, Del Giudice F et al (2016) Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications. Int J Impot Res 28:4–8CrossRefPubMed Antonini G, Busetto GM, De Berardinis E, Giovannone R, Vicini P, Del Giudice F et al (2016) Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications. Int J Impot Res 28:4–8CrossRefPubMed
2.
Zurück zum Zitat Simsek A, Kucuktopcu O, Ozgor F, Ozkuvanci U, Baykal M, Sarilar O et al (2014) Self and partner satisfaction rates after 3 part inflatable penile prosthesis implantation. Arch Ital Urol Androl 86:219–221CrossRefPubMed Simsek A, Kucuktopcu O, Ozgor F, Ozkuvanci U, Baykal M, Sarilar O et al (2014) Self and partner satisfaction rates after 3 part inflatable penile prosthesis implantation. Arch Ital Urol Androl 86:219–221CrossRefPubMed
3.
Zurück zum Zitat Evans C (1998) The use of penile prostheses in the treatment of impotence. Br J Urol 81:591–598CrossRefPubMed Evans C (1998) The use of penile prostheses in the treatment of impotence. Br J Urol 81:591–598CrossRefPubMed
4.
Zurück zum Zitat Kucuk EV, Tahra A, Bindayi A, Onol FF (2016) Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments. Andrology 4:952–956CrossRefPubMed Kucuk EV, Tahra A, Bindayi A, Onol FF (2016) Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments. Andrology 4:952–956CrossRefPubMed
5.
Zurück zum Zitat Bozkurt IH, Arslan B, Yonguç T, Kozacıoglu Z, Degirmenci T, Gunlusoy B et al (2015) Patient and partner outcome of inflatable and semi-rigid penile prosthesis in a single institution. Int Braz J Urol 41:535–541CrossRefPubMedPubMedCentral Bozkurt IH, Arslan B, Yonguç T, Kozacıoglu Z, Degirmenci T, Gunlusoy B et al (2015) Patient and partner outcome of inflatable and semi-rigid penile prosthesis in a single institution. Int Braz J Urol 41:535–541CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Minervini A, Ralph DJ, Pryor JP (2006) Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int 97:129–133CrossRefPubMed Minervini A, Ralph DJ, Pryor JP (2006) Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int 97:129–133CrossRefPubMed
7.
Zurück zum Zitat Natali A, Olianas R, Fisch M (2008) Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 5:1503–1512CrossRefPubMed Natali A, Olianas R, Fisch M (2008) Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 5:1503–1512CrossRefPubMed
8.
Zurück zum Zitat Carson CC 3rd, Mulcahy JJ, Harsch MR (2011) Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol 185:614–618CrossRefPubMed Carson CC 3rd, Mulcahy JJ, Harsch MR (2011) Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol 185:614–618CrossRefPubMed
9.
Zurück zum Zitat Nehra A, Carson CC 3rd, Chapin AK, Ginkel AM (2012) Long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery. J Urol 188:899–903CrossRefPubMed Nehra A, Carson CC 3rd, Chapin AK, Ginkel AM (2012) Long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery. J Urol 188:899–903CrossRefPubMed
10.
Zurück zum Zitat Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH et al (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection. J Bone Joint Surg Am 92:2102–2109CrossRefPubMed Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH et al (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection. J Bone Joint Surg Am 92:2102–2109CrossRefPubMed
11.
Zurück zum Zitat Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G et al (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11:55–59CrossRefPubMed Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G et al (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11:55–59CrossRefPubMed
12.
Zurück zum Zitat Lowsby R, Gomes C, Jarman I, Lisboa P, Nee PA, Vardhan M et al (2015) Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Emerg Med J 32:531–534CrossRefPubMed Lowsby R, Gomes C, Jarman I, Lisboa P, Nee PA, Vardhan M et al (2015) Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Emerg Med J 32:531–534CrossRefPubMed
13.
Zurück zum Zitat Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systematic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:218–230CrossRefPubMed Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systematic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:218–230CrossRefPubMed
14.
Zurück zum Zitat Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100:1236–1239CrossRefPubMedPubMedCentral Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100:1236–1239CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Yombi JC, Schwab PE, Thienpont E (2016) Neutrophil-to-lymphocyte ratio (NLR) distribution shows a better kinetic pattern than C-reactive protein distribution for the follow-up of early inflammation after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 24:3287–3292CrossRefPubMed Yombi JC, Schwab PE, Thienpont E (2016) Neutrophil-to-lymphocyte ratio (NLR) distribution shows a better kinetic pattern than C-reactive protein distribution for the follow-up of early inflammation after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 24:3287–3292CrossRefPubMed
16.
Zurück zum Zitat Paramanathan A, Saxena A, Morris DL (2014) Asystematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumors. Surg Oncol 23:31–39CrossRefPubMed Paramanathan A, Saxena A, Morris DL (2014) Asystematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumors. Surg Oncol 23:31–39CrossRefPubMed
17.
Zurück zum Zitat Josse JM, Cleghorn MC, Ramji KM, Jiang H, Elnahas A, Jackson TD et al (2016) The neutrophil/lymphocyte ratio predicts major perioperative complications in patients undergoing colorectal surgery. Colorectal Dis 18:O236–O242CrossRefPubMed Josse JM, Cleghorn MC, Ramji KM, Jiang H, Elnahas A, Jackson TD et al (2016) The neutrophil/lymphocyte ratio predicts major perioperative complications in patients undergoing colorectal surgery. Colorectal Dis 18:O236–O242CrossRefPubMed
18.
Zurück zum Zitat Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ (2007) Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 5:27–30CrossRefPubMed Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ (2007) Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 5:27–30CrossRefPubMed
19.
Zurück zum Zitat Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C (2007) Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 89:94–99CrossRefPubMed Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C (2007) Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 89:94–99CrossRefPubMed
20.
Zurück zum Zitat Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol 110:1405–1410CrossRefPubMed Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol 110:1405–1410CrossRefPubMed
21.
Zurück zum Zitat Chung E, Van CT, Wilson I, Cartmill RA (2013) Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol 31:591–595CrossRefPubMed Chung E, Van CT, Wilson I, Cartmill RA (2013) Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol 31:591–595CrossRefPubMed
22.
Zurück zum Zitat Cakan M, Demirel F, Karabacak O, Yalçinkaya F, Altuğ U (2003) Risk factors for penile prosthetic infection. Int Urol Nephrol 35:209–213CrossRefPubMed Cakan M, Demirel F, Karabacak O, Yalçinkaya F, Altuğ U (2003) Risk factors for penile prosthetic infection. Int Urol Nephrol 35:209–213CrossRefPubMed
23.
Zurück zum Zitat Sadeghi-Nejad H (2007) Penile prosthesis surgery: a review of prosthetic devices and associated complications. J Sex Med 4:296–309CrossRefPubMed Sadeghi-Nejad H (2007) Penile prosthesis surgery: a review of prosthetic devices and associated complications. J Sex Med 4:296–309CrossRefPubMed
24.
Zurück zum Zitat Levine LA, Becher E, Bella A, Brant W, Kohler T, Martinez-Salamanca JI et al (2016) Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med 13:489–518CrossRefPubMed Levine LA, Becher E, Bella A, Brant W, Kohler T, Martinez-Salamanca JI et al (2016) Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med 13:489–518CrossRefPubMed
26.
Zurück zum Zitat Martinez DR, Mennie PA, Carrion R (2012) Erectile function significant enough for penetration during sexual intercourse after removal of inflatable penile prosthesis. J Sex Med 9:2938–2942CrossRefPubMed Martinez DR, Mennie PA, Carrion R (2012) Erectile function significant enough for penetration during sexual intercourse after removal of inflatable penile prosthesis. J Sex Med 9:2938–2942CrossRefPubMed
27.
Zurück zum Zitat Martinez-Salamanca JI, Mueller A, Moncada I, Carballido J, Mulhall JP (2011) Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review. J Sex Med 8:1880–1889CrossRefPubMed Martinez-Salamanca JI, Mueller A, Moncada I, Carballido J, Mulhall JP (2011) Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review. J Sex Med 8:1880–1889CrossRefPubMed
28.
Zurück zum Zitat Carson CC (2003) Diagnosis, treatment and prevention of penile prosthesis infection. Int J Impot Res 15(Suppl 5):S139–S146CrossRefPubMed Carson CC (2003) Diagnosis, treatment and prevention of penile prosthesis infection. Int J Impot Res 15(Suppl 5):S139–S146CrossRefPubMed
29.
Zurück zum Zitat Mulcahy JJ, Brant MD, Ludlow JK (1995) Management of infected penile implants. Tech Urol 1:115–119PubMed Mulcahy JJ, Brant MD, Ludlow JK (1995) Management of infected penile implants. Tech Urol 1:115–119PubMed
30.
Zurück zum Zitat Lynch MJ, Scott GM, Inglis JA, Pryor JP (1994) Reducing the loss of implants following penile prosthetic surgery. Br J Urol 73:423–427CrossRefPubMed Lynch MJ, Scott GM, Inglis JA, Pryor JP (1994) Reducing the loss of implants following penile prosthetic surgery. Br J Urol 73:423–427CrossRefPubMed
31.
Zurück zum Zitat Shau H, Kim A (1988) Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141:4395–4402PubMed Shau H, Kim A (1988) Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141:4395–4402PubMed
32.
Zurück zum Zitat Djeu JY, Serbousek D, Blanchard DK (1990) Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 76:1405–1409PubMed Djeu JY, Serbousek D, Blanchard DK (1990) Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 76:1405–1409PubMed
33.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. AnnSurg 240:205–213 Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. AnnSurg 240:205–213
Metadaten
Titel
Neutrophil to Lymphocyte Ratio as a predictor of early penile prosthesis implant infection
verfasst von
Deniz Bolat
Yusuf Kadir Topcu
Ozgu Aydogdu
Suleyman Minareci
Cetin Dincel
Publikationsdatum
16.03.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 6/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1569-z

Weitere Artikel der Ausgabe 6/2017

International Urology and Nephrology 6/2017 Zur Ausgabe

Nephrology – Review

PCSK9 in chronic kidney disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.